Alert Number 123
Date: August 22, 2005
Today is a red letter day for us at CLL Topics.
It has been a long wait, a lot of hard work on part of the researchers and even us chickens at CLL Topics, hundreds of generous donors putting their money where their hearts are and contributing to our fund-raising efforts, but finally it is official. Project Alpha begins recruiting patients today. You can read all the details in our article Project Alpha Kicks Off.
This clinical trial has a number of “firsts”. It is the first formal clinical trial using EGCG (an extract of green tea) as a potential drug for treating CLL, in human volunteers. It is the first time that a patient group has worked closely with a premier institution such as Mayo Clinic to bring to the forefront a low toxicity therapy approach that is of interest to the patient community. It is the first time that a CLL patient group has sponsored and funded a clinical trial. It is the first time that CLL Topics has taken on such a challenging task. I can keep going, but you get the picture. I am as proud as I can be.
Ladies and Gentlemen, this is your trial. You sponsored it, you paid for it. That is quite an achievement. Congratulations!
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright © 2002-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.